Pfizer Agrees to Pay $60 Million to Settle Probe into Bribes

Pharmaceutical giant Pfizer Inc. has agreed to pay more than $60 million to settle an investigation by U.S. regulators into whether the drug maker paid bribes to win business abroad, the Wall Street Journal reported, citing people familiar with the matter. The U.S. Justice Department announced in November 2009 that it would focus on prosecuting those in the pharmaceutical industry who try to bribe foreign officials for preferential treatment of their products, leading to a wide-ranging probe.

Back to news